ORX.ST
Orexo AB
Price:  
15.00 
SEK
Volume:  
10,878.00
Sweden | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ORX.ST WACC - Weighted Average Cost of Capital

The WACC of Orexo AB (ORX.ST) is 6.5%.

The Cost of Equity of Orexo AB (ORX.ST) is 6.05%.
The Cost of Debt of Orexo AB (ORX.ST) is 7.45%.

Range Selected
Cost of equity 5.10% - 7.00% 6.05%
Tax rate 5.60% - 7.30% 6.45%
Cost of debt 7.00% - 7.90% 7.45%
WACC 5.8% - 7.1% 6.5%
WACC

ORX.ST WACC calculation

Category Low High
Long-term bond rate 2.5% 3.0%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.4 0.48
Additional risk adjustments 0.5% 1.0%
Cost of equity 5.10% 7.00%
Tax rate 5.60% 7.30%
Debt/Equity ratio 0.92 0.92
Cost of debt 7.00% 7.90%
After-tax WACC 5.8% 7.1%
Selected WACC 6.5%

ORX.ST's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for ORX.ST:

cost_of_equity (6.05%) = risk_free_rate (2.75%) + equity_risk_premium (5.60%) * adjusted_beta (0.4) + risk_adjustments (0.75%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.